By DAVID GELLES
Allergan on Monday told its shareholders not to hand over any stock to Valeant Pharmaceuticals, while Valeant said that Allergan’s rejection of its offer was based on assumptions “not supported by the facts.”
Published: June 23, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1paBCv2
from WordPress http://ift.tt/1j6ZKGL
via Hadi Aboukhater
No comments:
Post a Comment